[RNA interference: biogenesis molecular mechanisms and its applications in cervical cancer]
- PMID: 20415061
[RNA interference: biogenesis molecular mechanisms and its applications in cervical cancer]
Abstract
RNAi (RNA interference) is a natural process by which eukaryotic cells silence gene expression through small interference RNAs (siRNA) which are complementary to messenger RNA (mRNA). In this process, the siRNA that are 21-25 nucleotides long and are known as microRNA (miRNA), either associate with the RNA-induced silencing complex (RISC), which targets and cleaves the complementary mRNAs by the endonucleolytic pathway, or repress the translation. It is also possible to silence exogenous gene expression during viral infections by using DNA templates to transcribe siRNA with properties that are identical to those of bioactive microRNA. Persistent human papillomavirus (HPV) infection is the main etiological agent during cervical cancer development and the HPV E6 and E7 oncogenes, which induce cellular transformation and immortalization, represent strategic targets to be silenced with siRNA. In several in vitro and in vivo studies, it has been demonstrated that the introduction of siRNA directed against the E6 and E7 oncogenes in human tumoral cervical cells transformed by HPV, leads to the efficient silencing of HPV E6 and E7 oncogene expression, which induces the accumulation of the products of the p53 and pRb tumor suppressor genes and activates the mechanism of programmed cell death by apoptosis; thus, the progression of the tumoral growth process may be prevented. The goal of this review is to analyze the microRNA biogenesis process in the silencing of gene expression and to discuss the different protocols for the use of siRNA as a potential gene therapy strategy for the treatment of cervical cancer.
Similar articles
-
Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference.Oncogene. 2002 Sep 5;21(39):6041-8. doi: 10.1038/sj.onc.1205878. Oncogene. 2002. PMID: 12203116
-
RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53.Apoptosis. 2008 Feb;13(2):273-81. doi: 10.1007/s10495-007-0163-8. Apoptosis. 2008. PMID: 18060502
-
[RNA interference (RNAi) and its therapeutic potential in cancer].Rev Invest Clin. 2010 Jan-Feb;62(1):81-90. Rev Invest Clin. 2010. PMID: 20415062 Review. Spanish.
-
Silencing of HPV 18 oncoproteins With RNA interference causes growth inhibition of cervical cancer cells.Reprod Sci. 2007 Jan;14(1):20-8. doi: 10.1177/1933719106298189. Reprod Sci. 2007. PMID: 17636212
-
[Great potential of small RNAs: RNA interference and microRNA].Rev Invest Clin. 2006 Jul-Aug;58(4):335-49. Rev Invest Clin. 2006. PMID: 17146945 Review. Spanish.
Cited by
-
MicroRNAs transported by exosomes in body fluids as mediators of intercellular communication in cancer.Onco Targets Ther. 2014 Jul 21;7:1327-38. doi: 10.2147/OTT.S61562. eCollection 2014. Onco Targets Ther. 2014. PMID: 25092989 Free PMC article. Review.
-
Enhancement of silencing DNA polymerase β on the radiotherapeutic sensitivity of human esophageal carcinoma cell lines.Tumour Biol. 2014 Oct;35(10):10067-74. doi: 10.1007/s13277-014-2308-z. Tumour Biol. 2014. PMID: 25015190
-
microRNA-449a functions as a tumor-suppressor in gastric adenocarcinoma by targeting Bcl-2.Oncol Lett. 2013 Dec;6(6):1713-1718. doi: 10.3892/ol.2013.1609. Epub 2013 Oct 9. Oncol Lett. 2013. PMID: 24260067 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous